New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For UNH;MDT;AET;CVH;BSX;STJ;CNC;MOH;WLP;AGP;CI;HUM;HNT;HS;WCG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
July 22, 2015
07:00 EDTSTJSt. Jude Medical to acquire Thoratec for $63.50 per share, deal valued at $3.4B
Subscribe for More Information
July 21, 2015
16:28 EDTSTJOn The Fly: Top stock stories for Tuesday
Subscribe for More Information
15:08 EDTSTJThoratec reaches all-time high after report of St. Jude takeover
Subscribe for More Information
15:02 EDTSTJNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Coca-Cola (KO), consensus 60c... Boeing (BA), consensus $1.42... Abbott Laboratories (ABT), consensus 50c... Thermo Fisher Scientific (TMO), consensus $1.78... EMC (EMC), consensus 41c... Illinois Tool Works (ITW), consensus $1.28... St. Jude Medical (STJ), consensus $1.00... Northern Trust (NTRS), consensus 96c... Check Point Software (CHKP), consensus 95c... Polaris Industries (PII), consensus $1.58... Interpublic Group (IPG), consensus 27c... New York Community Bancorp (NYCB), consensus 26c... B/E Aerospace (BEAV), consensus 76c... Owens Corning (OC), consensus 54c... Knight Transportation (KNX), consensus 37c.
13:56 EDTSTJSt. Jude Medical bid for Thoratec makes strategic sense, says JPMorgan
Subscribe for More Information
12:40 EDTSTJSt. Jude in talks to acquire Thoratec, Bloomberg reports
St. Jude Medical (STJ) is in talks to acquire Thoratec (THOR), Bloomberg reports, citing people familiar with the situation. Talks are ongoing and could still fall apart as no deal has been reached, Bloomberg adds. Thoratec shares spiked early in today's session, but a catalyst for the move was unclear before the Bloomberg report. Shares of the medical device maker focused on advanced heart failure patients are up $9.52 to $58.33 in midday trading. Its close competitor HeartWare (HTWR) is now up $5.53 to $84.70. Shares of St. Jude are up 4 to $76.61. Reference Link
12:33 EDTSTJThoratec jumps after Bloomberg report of St. Jude buyout talks
Subscribe for More Information
12:29 EDTSTJSt. Jude Medical in talks to acquire Thoratec, Bloomberg reports
Subscribe for More Information
12:21 EDTSTJOn The Fly: Top stock stories at midday
Subscribe for More Information
10:20 EDTSTJCatalyst behind Thoratec spike higher unclear
The catalyst behind the spike higher in shares of Thoratec (THOR) is unclear to traders and investors. The medical device maker focused on advanced heart failure patients rose as high $62.05 in early trading and its shares remain up 11%, or $5.48, to $54.29. Some vague takeover chatter surfaced, with St. Jude Medical (STJ) as the speculated buyer, but buyout rumors are often the "go-to" reason when stocks spike. Often the moves on rumors are less substantial than Thoratec's spike today. The company's close competitor HeartWare (HTWR) is not seeing any unusual trading thus far today, falling 36c to $78.81 in early trading.
10:01 EDTHNT, CNCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:28 EDTCNCCentene downgraded to Sell from Neutral at Goldman
Goldman downgraded Centene (CNC) to Sell with a $69 price target. The firm's analyst believes Centene's acquisition of Health Net (HNT) is a signal of slower organic growth and makes the company a less likely M&A target. Goldman sees increasing execution risk given complex deal integration and lowered its price target to $69 from $73 on shares.
07:22 EDTBSXBoston Scientific should be bought on pullbacks, says RBC Capital
RBC Capital expects Boston Scientific to report slightly higher than expected Q2 EPS and in-line revenue. The firm expects the company's results to be boosted by strength in ICDs and OUS DES stents. RBC is confident that the company's EPS can grow by low teen percentage levels over the long-term and recommends buying the shares on pullbacks.
06:20 EDTHNTHealth Net downgraded to Neutral from Buy at Goldman
Subscribe for More Information
July 20, 2015
10:05 EDTHUMHumana renews, lengthens SilverSneakers pact with Healthways
Subscribe for More Information
09:08 EDTBSXBoston Scientific begins study of resorbable drug-eluting scaffold system
Boston Scientific has initiated a study of the company's first fully resorbable drug-eluting scaffold system. The Fully Absorbable Scaffold Feasibility Study, or FAST, is a prospective, single arm study designed to assess the safety and performance of this next generation scaffold for the treatment of atherosclerotic coronary lesions.
08:32 EDTSTJSt. Jude Medical receives FDA approval for MR-conditional 5-column paddle lead
Subscribe for More Information
July 17, 2015
10:21 EDTCICigna says 98.4% of customers treated with hep C drug Harvoni are cured
Subscribe for More Information
08:07 EDTMDTMedtronic shares undervalued, says Wells Fargo
Subscribe for More Information
07:50 EDTUNHUnitedHealth, Catamaran deal will close earlier than expected, says UBS
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use